Note: Ingredients listed on restricted chemical lists
EC/CAS
200-636-0/66-81-9
Name of the chemical
Cycloheximid
Concentration
N/A
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
200-075-1/50-99-7
Name of the chemical
Glucose C6H12O6
Concentration
N/A
General Information
Version
3
Revision date
2025-03-18
Product name
Cycloheximide
Emergency telephone
1-800-535-5053, 001-352-323-3500
Icons in SDS
Company Information
company name
Remel
e-mail address of the competent person responsible for the Safety Data Sheet
mbd-sds@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
SECTION 2: Hazards identification
CLP Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Classification of the substance or mixture GHS Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567
Physical hazards
Based on available data, the classification criteria are not met
Health hazards
Reproductive Toxicity Category 1B (H360D)
Environmental hazards
Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16
Signal word
Danger
Hazard statements
H360D - May damage the unborn child
Precautionary statements
P201 - Obtain special instructions before use P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical advice/attention Additional EU labelling Restricted to professional users
2.3 Other hazards
This product does not contain any known or suspected endocrine disruptors
2.1 Classification of the substance or mixture
GHS Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Physical hazards Based on available data, the classification criteria are not met Health hazards Reproductive Toxicity Category 1B (H360D) Environmental hazards Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16